CBCnews
Story Tools: EMAIL | PRINT | Text Size: S M L XL | REPORT TYPO | SEND YOUR FEEDBACK | Bookmark and Share

Inventor of LSD dies at age 102

Last Updated: Wednesday, April 30, 2008 | 5:53 AM ET

Albert Hofmann, the father of the mind-altering drug LSD whose medical discovery grew into a notorious illicit substance, died Tuesday. He was 102.

Albert Hofmann, discoverer of the mind-altering drug LSD and former head of the research department of Swiss chemical company Sandoz, is shown in 1998. He died Tuesday of a heart attack.Albert Hofmann, discoverer of the mind-altering drug LSD and former head of the research department of Swiss chemical company Sandoz, is shown in 1998. He died Tuesday of a heart attack. (Walter Bieri/Keystone/Associated Press)

Hofmann died of a heart attack at his home in Basel, Switzerland, according to Rick Doblin, president of the Multidisciplinary Association for Psychedelic Studies, in a statement posted on the association's website.

His death was confirmed to the Associated Press by Doris Stuker, a clerk in the village of Burg im Leimental, where Hofmann moved following his retirement in 1971.

Hofmann's hallucinogen inspired — and arguably corrupted — millions in the 1960s psychedelic era. For decades after LSD was banned in the late 1960s, Hofmann defended his invention.

"I produced the substance as a medicine.… It's not my fault if people abused it," he once said.

The Swiss chemist discovered lysergic acid diethylamide-25 in 1938 while studying the medicinal uses of a fungus found on wheat and other grains, at the Sandoz pharmaceuticals firm in Basel.

He became the first human guinea pig of the drug when a tiny amount of the substance seeped onto his finger during a repeat of the laboratory experiment on April 16, 1943.

Hofmann discovered the drug had a similar chemical structure to psychedelic mushrooms and herbs used in religious ceremonies by Mexican Indians.

Hofmann and his scientific colleagues hoped that LSD would make an important contribution to psychiatric research. The drug exaggerated inner problems and conflicts and thus it was hoped that it might be used to recognize and treat mental illnesses like schizophrenia.

LSD sold by Sandoz as medicine

For a time, Sandoz sold LSD 25 under the name Delysid, encouraging doctors to try it themselves. It was one of the strongest drugs in medicine — with just one gram enough to dose an estimated 10,000 to 20,000 people for 12 hours.

LSD was elevated to international fame in the late 1950s and 1960s thanks to Harvard professor Timothy Leary, who embraced the drug under the slogan "turn on, tune in, drop out." The film star Cary Grant and numerous rock musicians extolled its virtues in achieving true self discovery and enlightenment.

But aside from the psychedelic trips and flower children, horror stories emerged about people going on murder sprees or jumping out of windows while hallucinating. Heavy users suffered permanent psychological damage.

The United States government banned LSD in 1966 and other countries followed suit.

Hofmann maintained this was unfair, arguing that the drug was not addictive. He repeatedly maintained the ban should be lifted to allow LSD to be used in medical research.

He himself took the drug — purportedly on an occasional basis and out of scientific interest — for several decades.

"LSD can help open your eyes," he once said. "But there are other ways — meditation, dance, music, fasting."

Even so, the self-described "father" of LSD readily agreed that the drug was dangerous if in the wrong hands. This was reflected by the title of his 1979 book: LSD - my problem child.

Hofmann retired from Sandoz in 1971. He devoted his time to travel, writing and lectures — which often reflected his growing interest with philosophy and religious questions.

  •  
Story Tools: EMAIL | PRINT | Text Size: S M L XL | REPORT TYPO | SEND YOUR FEEDBACK | Bookmark and Share
 

World Headlines

Indonesian ferry sinks in storm
Rescuers saved more than 240 people aboard an Indonesian passenger ferry that sank Sunday in rough waters off Sumatra island, but at least 25 people have died, officials said.
Iranian forces practise defending nuke sites
Iran on Sunday began large-scale air defence war games aimed at protecting the country's nuclear facilities against any possible attack, state television reported.
China mine blast toll rises to 87
The death toll from a coal mine explosion in northern China rose to 87 on Sunday as rescue crews worked in frigid temperatures to reach 21 miners still trapped underground.
U.S. health-care bill clears Senate hurdle
Democrats united Saturday night to narrowly push historic health-care legislation past a key U.S. Senate hurdle over the opposition of Republicans eager to inflict a punishing defeat on President Barack Obama.
Italian police arrest Mumbai attack suspects
Italian police on Saturday arrested a Pakistani father and son accused of helping fund and providing logistical support for last year's terrorist attacks in Mumbai, India, authorities said.

People who read this also read …

Top CBCNews.ca Headlines

Headlines

Afghan prisoner transfers halted 'more than one time'
Canadian officials have halted the transfer of prisoners to Afghanistan's intelligence service "more than one time," because of the possibility of torture, Canada's chief of defence staff said Sunday.
Indonesian ferry sinks in storm
Rescuers saved more than 240 people aboard an Indonesian passenger ferry that sank Sunday in rough waters off Sumatra island, but at least 25 people have died, officials said.
Iranian forces practise defending nuke sites
Iran on Sunday began large-scale air defence war games aimed at protecting the country's nuclear facilities against any possible attack, state television reported.
Plaskett double winner at Canadian Folk Music Awards
Joel Plaskett's triple album Three earned the Halifax singer-songwriter a double win at the Canadian Folk Music Awards on Saturday.
Canadian speedskater Groves wins gold
Kristina Groves of Ottawa won her first World Cup gold of the season on Sunday, prevailing in the 1,500-metre race in Hamar, Norway.